ColonaryConcepts targets phase 3 trial for edible colonoscopy prep

A novel colonoscopy preparation designed to be more palatable for patients could be headed to a phase 3 trial next year after ColonaryConcepts announced it has reacquired its rights.Originally sold to Sebela Pharmaceuticals in 2017, EC Prep integrates active colonoscopy prep ingredients into “nutritionally balanced bars” and beverages, according to a press release.“EC Prep is a paradigm-shift in colon prep,” Herbert Stern, CEO of ColonaryConcepts, said in the release. “We remain convinced that millions of patients will benefit from the advance in colonoscopy prepRead More

Share on facebook
Share on twitter
Share on linkedin